Additional file 1: of Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

Table S1. Neuro-psychiatric adverse events grouping as a function of Medical Dictionary for Regulatory Activities (MedDRA) Classification Version 21.0. Table S2. Example of calculating reporting odds ratio (ROR) in Vigibase. Table S3. Clinical characteristics of patients with ICI-associated cerebral vasculitis collected from VigiBase. Table S4. Clinical characteristics of patients with ICI-associated myasthenia gravis collected from VigiBase. Table S5. Clinical characteristics of patients with ICI-associated encephalitis/myelitis collected from VigiBase. Table S6. Clinical characteristics of patients with ICI-associated Guillain-Barre Syndrome collected from VigiBase. Table S7. Clinical characteristics of patients with ICI-associated non-infectious meningitis collected from VigiBase. (DOCX 38 kb